The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Updated efficacy and safety of zurlectrectinib in adult patients (pts) with locally advanced or metastatic NTRK fusion–positive (NTRK+) solid tumors.
 
Dan-yun Ruan
No Relationships to Disclose
 
Rui-Hua Xu
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; BeiGene; Hutchison MediPharma; Junshi Pharmaceuticals; Keymed Biosience; MSD; QiLu Pharmaceutical
 
XingYa Li
No Relationships to Disclose
 
Xiaorong Dong
No Relationships to Disclose
 
Kunyu Yang
No Relationships to Disclose
 
Lin Wu
No Relationships to Disclose
 
Xianan Li
No Relationships to Disclose
 
Qiming Wang
No Relationships to Disclose
 
Nong Xu
No Relationships to Disclose
 
Jianya Zhou
No Relationships to Disclose
 
Zhe-Hai Wang
Consulting or Advisory Role - Hansoh Pharma
Research Funding - Hansoh Pharma (Inst)
 
Dongyuan Zhu
No Relationships to Disclose
 
Shundong Cang
No Relationships to Disclose
 
Baogang Liu
No Relationships to Disclose
 
Zhiguo Luo
No Relationships to Disclose
 
Jie Gao
Employment - Beijing InnoCare Pharma Tech
 
Xuan Pu
Employment - Beijing InnoCare Pharma Tech
 
Sizhe Chen
Employment - Beijing InnoCare Pharma Tech
 
Bin Zhang
Employment - Beijing InnoCare Pharma Tech
 
Renbin Zhao
Employment - Beijing InnoCare Pharma Tech